{"nct_id":"NCT05585034","title":"Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2022-12-14","start_date_type":"ACTUAL","primary_completion_date":"2025-05-20","primary_completion_date_type":"ACTUAL","completion_date":"2025-05-20","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["XNCR"]}